Suono Bio
Revolutionizing targeted gastrointestinal treatments
Cambridge, United States · Founded 2017 · $8.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- suonobio.com
- Total Funding
- $8.5M
- Last Round
- $8.5M Series AJul 2021
- Rounds
- 2
About
Suono Bio is a Foxborough, Massachusetts-based biotechnology company founded in 2017 as an MIT spinout that harnesses a proprietary ultrasound-based drug delivery platform to enable localized delivery of small molecules, biologics, nucleic acids, and gene therapies to the gastrointestinal tract without encapsulation. The platform, developed from 30 years of discoveries in MIT labs, can treat difficult-to-treat inflammatory and GI diseases with superior effectiveness compared to conventional systemic delivery. Backed by MIT's The Engine and Fujifilm, Suono Bio aims to revolutionize targeted GI therapeutics.
Summary
Suono Bio is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $8.5M in total across 2 rounds, most recently a $8.5M Series A round in Jul 2021. Investors include Axil Capital, Mizuho Securities Principal Investment and The Engine.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...